IL10 and congenital rubella syndrome: CRS‐related cytokines including IL‐6, IL‐10, sCD25, TNF‐γ and SF quickly decreased in these four patients after ruxolitinib intervention, which implicates that ruxolitinib successfully stops these cytokines release.